CSF3R mutations can be detected in approximately 80% of patients with chronic neutrophilic leukemia (CNL), and CSF3R mutations are now used as specific diagnostic molecular markers for CNL and atypical chronic myeloid leukemia (aCML) (22). Here, CSF3R is linked to chronic myelogenous leukemia, BCR-ABL1 positive.